Next, to test the influence of IFITM4P on anti-PD-1 therapy, we utilized an anti-PD-1 mAb to treat C57BL/6 mice inoculated with melanoma (B16F10) cells overexpressing the control vector or IFITM4P (Figure 4A). Here, IFITM4P is linked to melanoma.